Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans

Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg

Gunnar Tepe, Thomas Zeller, Thomas Albrecht et al. · New England Journal of Medicine · 2008 · 798 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery

Dorothea I. Axel, W Kunert, Christoph Göggelmann et al. · Circulation · 1997 · 782 citations

Medicine, Oncology, Pharmacology +11

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Kenneth Rosenfield, Michael R. Jaff, Christopher J. White et al. · New England Journal of Medicine · 2015 · 671 citations

Medicine, Cardiology, Surgery +16

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

Gunnar Tepe, John R. Laird, Peter A. Schneider et al. · Circulation · 2014 · 667 citations · Full text

Medicine, Surgery, Interventional Cardiology +15

The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization

Dierk Scheinert, Stephan H. Duda, Thomas Zeller et al. · JACC: Cardiovascular Interventions · 2014 · 395 citations

Medicine, Surgery, Interventional Cardiology +12